Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: April 8, 2025
BufferGel
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Gel
  • Intended Duration: Short-Acting
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): ReProtect Inc.
Inactive
Last updated: April 8, 2025
Bright Pill
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Undetermined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Bar-Ilan University
Inactive
Last updated: April 8, 2025
Biodegradable LNG Implant
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Peking University, Institute of Biomedical Engineering at Chinese Academy of Medical College
Inactive
Last updated: April 8, 2025
Biodegradable Foam Delivery System
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal - Other
  • Intended Duration: Pericoital
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): University of Cincinnati, FHI 360
Inactive
Last updated: April 8, 2025
Binding/Penetrating Enzymes
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Undetermined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Norfolk State University
Inactive
Last updated: April 2, 2025
Androgen Restored Contraception

ARC, Triple Hormone Contraceptive, Triple OC, Female-Balance Pill, Pill Plus, EE/DRSP/DHEA Pill

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Oral
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): ANI Pharmaceuticals, Pantarhei Bioscience
Active
Last updated: April 2, 2025
6-Month Microneedle Array Patch
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Intradermal
  • Intended Duration: Short-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Massachusetts Institute of Technology
Inactive
Last updated: April 2, 2025
3-DRIUD
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Shandong Provincial Institute, China, Technology for Family Planning, China